PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Chasing pots of Vioxx gold



No surprise here, especially since hundreds and even thousands of suits were already in progress alleging injury from Merck's just-withdrawn arthritis drug: "plaintiff attorneys are gearing up for a repeat of the Baycol, Rezulin and fen-phen torts. After Thursday's recall, firms around the country rushed to send mass e-mails and issue press releases to recruit Vioxx litigants." (Law.com).

 

 


Rafael Mangual
Project Manager,
Legal Policy
rmangual@manhattan-institute.org

Katherine Lazarski
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.